Table 3. Determination of Absolute Change and Statistical Significance between Pre- and Post-Treatment Values for Placebo and “Curcumin”^a Groups from COPD Subjects (Within-Group Analysis).

	absolute changeb		unpaired t testc
parameter	placebo	treatment	placebo	treatment
BMI, kg/m2	–0.17	0.2	0.872	0.724
SBP, mmHg	1.8	–1.7	0.805	0.768
DBP, mmHg	2.0	2.5	0.584	0.528
HbA1c, %	0.0	0.0	1.000	0.829
BS, mg/dL	14.3	6.0	0.216	0.456
TG, mg/dL	23.2	13.5	0.479	0.529
LDL-C, mg/dL	11.9	4.9	0.205	0.528
HDL-C, mg/dL	1.2	–1.7	0.723	0.668
UA, mg/dL	0.1	0.2	0.752	0.581
γ-GTP, IU/L	–0.5	–3.0	0.952	0.803
Cre, mg/dL	0.0	0.0	0.898	0.656
CRP, mg/dL	0.0	0.0	0.790	0.818
SAA-LDL, μg/mL	1.0	–0.3	0.676	0.973
AT-LDL, μg/mL	0.2	0.0	0.075	0.810
FEV1, %	–2.3	–1.2	0.287	0.554

^aSee main text for comments on the intervention agent.

^bCalculated from the baseline data in Funamoto et al.⁴ and the end of treatment values determined in Table 2 (vide supra).

^cBaseline to end of treatment for each value, within group.